Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases. Our lead indication is for treatment of Primary Open-Angle Glaucoma. Mannin Research is a research stage biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases using the Tie2 mechanism of act...
Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases. Our lead indication is for treatment of Primary Open-Angle Glaucoma. Mannin Research is a research stage biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases using the Tie2 mechanism of action. Mannin’s Tie2 platform technology addresses a number of vascular disease indications. Mannin is currently developing a small molecule to reduce intra-ocular pressure.

List your booth number for exhibitions, ask us